Acupuncture was superior to placebo needling in improving dyspnea and other outcomes among a cohort of patients with COPD, researchers reported.

Last month, Rocker et al highlighted discrepancies between the positive experiences of patients and family caregivers with the use of opioids for refractory dyspnea, and the reluctance of Canadian physicians to prescribe such therapy. This gap in clinical care is difficult to explain, particularly in the context of extensive exploration of the safety and efficacy of the therapy.